Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer: A Cross‐Sectional Study
Health Science Reports · 2026-07 · 9 (7)
DOI: 10.1002/hsr2.72780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 06.07.2026. Verfasst von Shayan Forghani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Advanced breast cancer is a leading cause of cancer‐associated death in women. It is critical to find biomarkers to identify patients who are more prone to progress to advanced disease and would be better served with more aggressive treatments. Hormone receptor‐positive breast cancers make up about 70% of all breast cancers. The analysis of gene amplification and expression has been utilized to classify breast tumors into medically useful risk groups. In the present study, we selected five genes ( MMP11 , CTSV , CD68 , SCUBE2 , and MYBL2 ) that are important in tumor invasion and metastasis to identify a pattern associated with well‐established pathology markers indicative of poor prognosis in early‐stage hormone receptor‐positive breast cancers.
Methods
Two hundred and thirty‐nine early‐stage hormone receptor‐positive breast cancer patients were analyzed. Patients were required to have FFPE (formalin‐fixed paraffin‐embedded) samples from the primary tumor. Expression of the selected genes was determined using TaqMan expression assays. MYBL2 amplification was examined using fluorescent in situ hybridization (FISH).
Results
Expression of CTSV was significantly associated with increasing tumor size ( p = 0.001) and lymph node involvement ( p = 0.016). In multivariate analysis, CTSV expression remained significantly associated with lymph node involvement ( p = 0.049). Expression of MYBL2 was associated with higher tumor grade ( p = 0.001). We identified MYBL2 amplification in one sample. Expression of SCUBE2 was inversely associated with tumor grade ( p = 0.04). Receiver‐operator characteristic (ROC) analysis was used to predict lymph node involvement using clinicopathologic features (age at diagnosis, tumor size, and histologic grade), and the five gene expression markers, which resulted in AUC = 0.83.
Conclusion
We found a significant association between CTSV , MYBL2 , and SCUBE2 expression and pathological variables of poor prognosis. Our study reveals that analysis of the expression of these genes may help identify early‐stage hormone receptor‐positive breast tumors that are more likely to metastasize and need more intense treatment modalities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
- Department of Hematology-oncology Shahid Beheshti University of Medical Sciences Tehran Iran.
ORCID-Profile: Fatemeh Mahdavi Sabet, Sanaz Tabarestani
Zitieren
APA
Forghani, S., Rezvani, H., Forghani, A., Sabet, F. M., Akbari, A., Tabarestani, S., & Mirzaee, H. R. (2026). Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer: A Cross‐Sectional Study. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72780
Vancouver
Forghani S, Rezvani H, Forghani A, Sabet FM, Akbari A, Tabarestani S, et al. Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer: A Cross‐Sectional Study. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72780
BibTeX
@article{Forghani2026,
author = {Forghani, Shayan and Rezvani, Hamid and Forghani, Arman and Sabet, Fatemeh Mahdavi and Akbari, Atieh and Tabarestani, Sanaz and Mirzaee, Hamid Reza},
title = {Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer: A Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/hsr2.72780}
}
EUVIMED